Business
Greengro Signs Cannabis Genetic JV with Acclaimed Plant Geneticist
Greengro Signs Cannabis Genetic JV with Acclaimed Plant Geneticist.
About this update from Greengro Technologies, Inc.
[{"type":"text","content":"\n\n ANAHEIM, Calif., June 19, 2017 (GLOBE NEWSWIRE) -- Greengro Technologies, Inc. (OTC:GRNH), a world-class provider of eco-friendly horticulture technologies, today announced it has signed a joint venture with Maqsood Rehman, Ph.D., a leading horticulture geneticist, for the development, patenting and licensing of cannabis strains.\n The JV is between GenoBreeding, a majority-owned Greengro subsidiary, and Dr. Rehman. Under the terms of the agreement, GenoBreeding will own 60 percent of the JV, and Dr. Rehman 40 percent. As was disclosed just last week, the Company’s GenoBreeding has already signed it first customer, igot420. Dr. Rehman brings 15 years’ successful experience and industry leadership including five years with Monsanto Company, and five years with Dow Agrosciences. To implement the JV’s business plan for surpassing the current industry state of cannabis strain development, he and his scientific team will utilize advanced technologies including breeding methods, genome sequencing, development of new molecular markers for key traits, and bioinformatics (software tools to develop predictive breeding methods). The Company is confident its proprietary combination and utilization of these tools, under the painstaking direction of one of the nation’s best qualified plant geneticists, will yield valuable new strains of cannabis and push the edge of the technology to new levels of science. His team includes two master cannabis growers and a molecular genetics and data development scientist. The combination and relative potency of about 200 terpenes, flavonoids, cannabinoids including THC, CBD and other molecular constituents give various strains of cannabis their distinctive flavors, scents and therapeutic properties. The number of combinations of these constituents, at differing potencies, is unlimited. The strains GenoBreeding selects for commercialization will be patented, assigned bar codes and included in its growing library for licensing, to companies such as igot420 for example. Initially, the commercialization strategy targets growers, producers and dispensaries seeking their own proprietary marijuana strains, in their own name, to build brand equity as well as to be able to offer customers unique, high quality strains to build brand loyalty. Secondarily, the Company will target the rapidl...